BSE Live
Nov 28, 16:01Prev. Close
2248.95
Open Price
2249.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 28, 15:59Prev. Close
2249.30
Open Price
2259.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2251.00 (35)
| Cash Flow of Mankind Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 10 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 558.31 | 485.58 | 396.45 | 278.23 | 249.46 | |
| Net CashFlow From Operating Activities | 956.75 | 355.00 | 302.53 | -12.85 | 134.50 | |
| Net Cash Used In Investing Activities | -44.62 | -358.15 | -285.77 | 20.74 | -84.29 | |
| Net Cash Used From Financing Activities | -107.58 | -1.41 | -1.40 | -2.15 | -10.27 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 804.56 | -4.55 | 15.36 | 5.74 | 39.94 | |
| Cash And Cash Equivalents Begin of Year | -777.82 | 104.51 | 89.15 | 83.41 | 59.61 | |
| Cash And Cash Equivalents End Of Year | 26.73 | 99.96 | 104.51 | 89.15 | 99.55 |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y